Complete guide to Sahajanand Medical Mainboard IPO: latest Grey Market Premium (GMP), live bidding subscription status, price band, lot size, financial report, and investment analysis.
📊 Overview & Key Highlights
| Parameter | Details |
|---|---|
| Issue Type | Mainboard IPO (BSE, NSE) |
| Issue Dates | 15 - 19 Oct |
| Price Band | ₹327 to ₹344 |
| Total Issue Size | 1,38,22,116 shares (agg. up to ₹475 Cr) |
| Minimum Market Lot | 43 shares (Min. Inv: ₹14,792) |
| Current GMP | ₹15 (Est. Listing: ₹359 (4.36%)) (Updated: 22 Oct, 15:15) |
| Subscription Status | 14.21x (Final / Bidding Closed) |
| Investor Demand Rating | ⭐⭐⭐⭐☆ (4/5 - Strong Demand) |
📈 Live Subscription Demand
| Category | Subscription Multiplier (x) |
|---|---|
| Qualified Institutional (QIB) | 34.70x |
| Non-Institutional / HNI | 14.64x |
| Retail Individual (RII) | 3.04x |
| Total Subscription | 14.21x (Updated: 22 Oct, 17:45) |
🎯 Investment Analysis & Verdict
📌 Business Model & Revenue Streams
Sahajanand Medical designs, manufactures and sells medical devices such as imaging systems, patient monitors and surgical instruments. Its customers are hospitals, diagnostic centres and clinics that purchase the equipment outright or under service contracts.🚀 Key Strengths & Growth Drivers
• Established OEM capabilities with a portfolio that meets Indian regulatory standards, giving it an edge over import‑dependent rivals.• Wide distribution network reaching both metro and tier‑2/3 cities, allowing it to capture rising demand from expanding healthcare infrastructure.
• Government push for domestic medical‑device manufacturing and “Make in India” incentives bolster long‑term market tailwinds.
⚠️ Key Risks & Red Flags
• High capital intensity; working‑capital needs rise sharply with inventory and R&D spend, potentially squeezing cash flow.• Concentration risk: a few large hospital groups account for a sizable share of sales, making revenue vulnerable to contract renegotiations.
• Debt levels have risen to fund new product lines; servicing that debt could become a pressure point if sales slow.
🎯 Retail Verdict
The IPO offers exposure to a growing domestic medical‑device market, but the business is capital‑heavy and somewhat client‑concentrated. It may suit investors looking for a medium‑term play on Indian healthcare expansion, yet retail participants should be comfortable with the liquidity and debt risks before committing.📅 Tentative Timetable
| Event | Tentative Date |
|---|---|
| IPO Open | Thu, Oct 15, 2026 |
| IPO Close | Mon, Oct 19, 2026 |
| Allotment | Wed, Oct 21, 2026 |
| Refund | Thu, Oct 22, 2026 |
| Credit of Shares | Thu, Oct 22, 2026 |
| Listing | Fri, Oct 23, 2026 |
💼 Market Lot & Investment Sizing
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 43 | ₹14,792 |
| Retail (Max) | 13 | 559 | ₹1,92,296 |
| S-HNI (Min) | 14 | 602 | ₹2,07,088 |
| S-HNI (Max) | 67 | 2881 | ₹9,91,064 |
| B-HNI (Min) | 68 | 2924 | ₹10,05,856 |
💰 Financial Summary
| Period Ended | Revenue | Expense | PAT | Assets |
| 2023 | ₹803.28 | ₹771.98 | ₹11.93 | ₹911.63 |
| 2024 | ₹908.59 | ₹875.50 | ₹7.35 | ₹970.58 |
| 2025 | ₹1,035.96 | ₹980.12 | ₹25.15 | ₹1,094.90 |
🏢 About Sahajanand Medical
Sahajanand Medical Technologies specializes in the design, development, and manufacture of high-quality medical devices and equipment tailored for diagnostic and therapeutic applications. The company serves a broad spectrum of healthcare providers, including hospitals, diagnostic centers, and clinics, with a focus on delivering reliable, precision-engineered solutions. Its product portfolio spans critical medical technologies, including imaging systems, patient monitoring devices, and surgical instruments, catering to both urban and semi-urban markets across India. With a strong emphasis on innovation and regulatory compliance, the firm supports the broader healthcare ecosystem by enhancing diagnostic accuracy and operational efficiency for medical professionals.📬 Registrar & Allotment Information
MUFG Intime India Pvt. Ltd. Phone: 022-49186000 Email: sahajanandmedical.ipo@in.mpms.mufg.com Website:💬 Community Discussion & Views
Are you planning to apply for the Sahajanand Medical IPO? Share your bidding strategy, allotment status, or listing expectations with fellow investors in the replies below!👉 Browse all upcoming Mainboard & SME IPOs on UNP
Disclaimer: All IPO details provided above are for educational and informational purposes only. Readers are advised to consult their financial advisors and review the Red Herring Prospectus (RHP) before investing.
📌 Thread Quick Navigation: Post #2: Live & Historic GMP | Post #3: Subscription Stats | Post #4: Allotment Status | Post #5: Listing Debut | Post #6: Community & Social Reviews
Last edited: